Related topics: Industry Drivers
Indian generics firm Dr Reddy’s plans to focus on the US, the world’s biggest drug market, and cut back in other regions to help it weather the global economic storm.
The non-branded major told the country’s Economic Times it will reduce its operations in the Commonwealth of Independent States (CIS), the Middle East and Africa and will close several facilities in China.
The paper quotes an unnamed company spokesman as saying "as part of our strategy, we continue to review our presence in various geographies based on the opportunities and attractiveness of those markets," and that Dr Reddy’s would align resources to meet its strategic priorities.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
